Star fund managers – an investing style that’s out of fashion
Star fund managers such as Terry Smith and Nick Train are at the mercy of wider market trends, says Cris Sholto Heaton
Two of Britain’s most acclaimed star fund managers – Terry Smith and Nick Train – are both struggling with a multi-year spell of disappointing returns. Yet they are reacting in very different ways. Smith seems inclined to blame passive investing, company management, the state of the economy, analysts, the state of the market in general and practically everybody else, as seen in his latest letter. Conversely, Train has castigated himself and apologised at length for letting investors down, as anybody who attended the Finsbury Growth and Income (LSE: FGT) meeting this month will know.
The truth surely lies between the extremes. Train has made mistakes in stock selection, but so has Smith (as we all do). At the same time, both have a particular style and are biased towards a type of company that is out of favour in today’s markets. Almost all managers will do better in certain market regimes than others. Recognising that is crucial to deciding where to invest and what expectations are reasonable.
Both star fund managers have had to change their approach to investing
Both Smith and Train have focused – in slightly different ways – on what they see as quality companies: businesses that can grow earnings steadily, earn strong returns on capital and compound over time. They were heavily invested in areas such as consumer staples and placed considerable value on dominant brands. These kinds of companies did very well for much of the 2010s, but many have struggled this decade – not just in relative terms (understandable in a tech bull market) but in absolute terms as well.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
There is a range of reasons for this. The era of ultra-low interest rates made the steady and rising income from these kinds of stocks very attractive, which pushed up valuations too high by the end of the decade. The post-pandemic inflation spike and cost-of-living pressures have hurt their ability to keep growing earnings either by selling more or by raising prices.
Emerging-market growth – a key part of the bull case for many – has been patchier than expected. More recently, GLP-1 weight loss drugs may be starting to weigh on demand not just for food but other products such as alcohol (it remains unclear how significant this is).
As these issues have become more obvious, both managers have adjusted their approach. Train is tilting towards data and digital businesses. Smith has shifted more into tech – moving in and out of some stocks with uncharacteristic speed – and has increased his exposure to healthcare. The thesis behind all these sectors is clear.
At the same time, we should note market conditions may not be as helpful to large incumbents as they were in the 2010s. There is far more uncertainty. Will data and software businesses capitalise on AI or be undermined by it? Will healthcare costs and margins come under attack in a much more populist political environment? We just can’t know at this point, and Smith is right to say that investors should be ever more alert for strategic missteps.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Get the latest financial news, insights and expert analysis from our award-winning MoneyWeek team, to help you understand what really matters when it comes to your finances.

Cris Sholt Heaton is the contributing editor for MoneyWeek.
He is an investment analyst and writer who has been contributing to MoneyWeek since 2006 and was managing editor of the magazine between 2016 and 2018. He is experienced in covering international investing, believing many investors still focus too much on their home markets and that it pays to take advantage of all the opportunities the world offers.
He often writes about Asian equities, international income and global asset allocation.
-
The enshittification of the internet – what it means for usWhy do transformative digital technologies start out as useful tools but then gradually get worse and worse? There is a reason for it – but is there a way out?
-
MoneyWeek news quiz: How many bank branches have closed in past decade?The price of gold and silver made headlines this week, as did the Lifetime ISA and more bank branch closures. How closely have you been following the news?
-
Affordable Art Fair: The art fair for beginnersChris Carter talks to the Affordable Art Fair’s Hugo Barclay about how to start collecting art, the dos and don’ts, and more
-
Three promising emerging-market stocks to diversify your portfolioOpinion Omar Negyal, portfolio manager, JPMorgan Global Emerging Markets Income Trust, highlights three emerging-market stocks where he’d put his money
-
Coface offers excess profit in an unloved sectorCoface is a world leader in trade-credit insurance with key competitive advantages in a niche market
-
Exciting opportunities in biotechBiotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make acquisitions
-
How to invest in the new breed of payment providersUpstart payment providers are taking the world by storm. It’s time for investors to buy in, says Rupert Hargreaves
-
What turns a stock market crash into a financial crisis?Opinion Professor Linda Yueh's popular book on major stock market crashes misses key lessons, says Max King
-
How to add cryptocurrency to your portfolioA new listing shows how bitcoin might add value to a portfolio if cryptocurrency keeps gaining acceptance, says Cris Sholto Heaton
-
Profit from pest control with Rentokil InitialRentokil Initial is set for global expansion and offers strong sales growth